Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426
- Citation:
- J Clin Oncol vol 28 (4) 614-619
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 399
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. A. Adjei S. J. Mandrekar G. K. Dy J. R. Molina D. R. Gandara K. L. Ziegler P. J. Stella K. M. Rowland Jr S. E. Schild R. G. Zinner
- Networks:
- Study
- NCCTG-N0426
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: